Walgreens Maximum Strength Acne Treatment Gel

Manufacturer
WALGREEN COMPANY
Effective date
2026-06-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
monthly-update
Hydrated at
2026-07-17 21:37:11

Label at a glance#

ProductWalgreens Maximum Strength Acne Treatment
Active ingredientBENZOYL PEROXIDE
Label structure10 sections

Indications and uses

for the treatment of acne

Dosage and administration

Clean the skin thoroughly before applying this product. Cover the entire afffected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor If bothersome dryness or peeling occurs, reduce application to once a day or every other day. If going outside, ap...

Storage and handling

Store at 20 o C - 25 o C (68 o F - 77 o F)

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzoyl peroxide 10.0%

Purpose

OTC - PURPOSE SECTION

Acne Medication

Uses

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes, lips and mouth
  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with hair and dyed fabrics which may be bleached by this product
  • skin irritation may occur, characterized by redness, burning, itching, peelin, or possibly swelling. Irritation may be reduced by using the product les frequently or in a lower concentration.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product.
  • Cover the entire afffected area with a thin layer one to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
  • If going outside, apply sunscreen after using this product. If irritation or sensitvity develops, stop use of both products and ask a doctor.

Other information

STORAGE AND HANDLING SECTION

Store at 20 oC - 25 oC (68 oF - 77 oF)

Inactive ingredients

INACTIVE INGREDIENT SECTION

carbomer, disodium EDTA, hydroxypropyl methylcellulose, laureth-4, sodium hydroxide, tocopheryl acetate, water.

Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelLabelLabel InnerLabel Inner

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0363-13630363-1363-16, 0363-1363-17

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Walgreens Maximum Strength Acne TreatmentBENZOYL PEROXIDEWALGREEN COMPANY548e327b-1a4f-03df-e063-6294a90a39322026-06-18WarningsExact identifier
ndc (package): 0363-1363-16
ndc (package): 0363-1363-17
ndc (product): 0363-1363
ndc11 (package): 00363136317
ndc11 (package): 00363136316
spl id: 548e2621-eb31-f1c5-e063-6294a90a2844
spl set id: 548e327b-1a4f-03df-e063-6294a90a3932

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.